Overview Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors Status: Completed Trial end date: 2008-02-01 Target enrollment: Participant gender: Summary Phase 1, Multiple Dose Study of MPC-6827 in Subjects with Refractory Solid Tumors. Phase: Phase 1 Details Lead Sponsor: Myrexis Inc.